Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients

doi:10.3748/wjg.v18.i38.5434

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3765)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

291

HTML

3088

Figures (1-3)

195

Tables (1-2)

191

Sum=3765

Oct 14, 2012 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 14, 2012; 18(38): 5434-5441
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5434

Full Size Figure Download Figure

Figure 3 Postoperative survival curves in patients with stage I-IV carcinoma. Myofibrillogenesis regulator-1 (MR-1) protein positive expression refers to cases showing weak and moderate staining.

Citation: Guo J, Dong B, Ji JF, Wu AW. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. World J Gastroenterol 2012; 18(38): 5434-5441
URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5434.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i38.5434